US Pharma MarketingARPA-H awards $125M for manufacturing custom RNA therapies on demand
ARPA-H awards up to $125M across 5 teams, including Waterfall Scientific, to build automated systems that can make personalized RNA medicines in under a week. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene…
The dream of making personalized genetic medicines at a moment’s notice just got a major infusion of funding from the federal government.
Five groups were collectively awarded up to $125 million ...
Source: Endpoints News